It has been reported that polyclonal antibodies induced by vaccination to recognize different epitopes of HER2, a membrane-bound receptor for tumor growth, can have multiple effects on HER2 function, and efficiently decrease the seeding rate of HER2-dependent tumor xenografts [28]. This evidence concerns the gene ERBB2 and neoplasm.